Dr. Michael D. Prados, MD

PNOC Co-Founder, Co‑Project Leader

Dr. Michael D. Prados is a neuro-oncologist whose career at UCSF spans more than three decades, encompassing the care of both adults and children with brain tumors, as well as leadership in translational and early-phase clinical trials. He co-founded the Pediatric Neuro-Oncology Consortium (PNOC) and co-leads its project portfolio, helped launch and co-chaired the Children’s Brain Tumor Network (CBTN), and has published 350+ papers advancing therapy development and precision neuro-oncology. He holds the Charles B. Wilson, MD, Endowed Chair in Neurological Surgery and has served as President of the Society for Neuro‑Oncology (SNO).

Education

Education

  • BS, University of New Orleans, LA

  • MD, LSU Health New Orleans, LA

  • Internship, Internal Medicine, Charity Hospital (Medical Center of Louisiana at New Orleans)

  • Residency, Internal Medicine, Earl K. Long Medical Center / LSU

  • Fellowship, Pulmonary Disease, Tulane University School of Medicine

  • Fellowship, Neuro‑Oncology, UCSF

Certifications

Certifications

  • American Board of Internal Medicine, Internal Medicine (1977)

Awards

Awards & Recognition

  • Victor Levin Award for lifetime excellence in clinical research, Society for Neuro‑Oncology (2014)

  • President, Society for Neuro‑Oncology (2004–2006); Vice President (1995–1997)

  • Clinical Excellence Award, Society for Neuro‑Oncology (1997)

  • Scientific Executive Co‑Chair, Children’s Brain Tumor Network (CBTN) (former)

Research & Publications

Selected Research & Clinical Publications

  • Friedman HS, Prados MD, Wen PY, et al. Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma. J Clin Oncol. 2023;41(32):4945–4952. doi:10.1200/JCO.22.02772. Available from: https://pubmed.ncbi.nlm.nih.gov/37935104

  • Mueller S, Kline C, Lu AY, Hoogendijk R, Wembacher‑Schroeder E, Banerjee A, Reddy AT, Raber S, Hoffman C, Stoller S, Prados M, Molinaro A, Gupta N. PNOC009: Convection‑enhanced delivery of liposomal irinotecan in patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro‑Oncol Adv. 2025;7(1):vdaf093. doi:10.1093/noajnl/vdaf093. Available from: https://pubmed.ncbi.nlm.nih.gov/40575415

  • Prados MD. Current Strategies for Management of Medulloblastoma. Diagnostics (Basel). 2023;13(16):2622. doi:10.3390/diagnostics13162622. Available from: https://www.mdpi.com/2075-4418/13/16/2622